Hanmi-MSD’s export agreement of ‘Rosuzet,’ hyperlipidemia combination drug, to 23 countries
Hanmi-developed ‘Rosuzet’ will be exported to 23 foreign countries via MSD.
It was announced on the 4th Hanmi Pharm and MSD has recently signed a license agreement of exporting Rosuzet and decided to export three different volumes of Rosuzet(10/5mg, 10/10mg and 10/20mg) to 23 countries.
Rosuzet...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
